AVITA Medical to Present at the Piper Sandler 36ᵗʰ Annual Healthcare Conference
November 25 2024 - 4:02PM
AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage
regenerative medicine company focused on first-in-class devices for
wound care management and skin restoration, today announced that
Jim Corbett, Chief Executive Officer, will present at the at the
Piper Sandler 36th Annual Healthcare Conference on Tuesday,
December 3, 2024, at 11:30 a.m. Eastern Time.
A live webcast of the fireside chat will be accessible under the
Events & Presentations section of the Company's website at
https://ir.avitamedical.com. A replay of the webcast will be
available following the conclusion of the event.
About AVITA Medical, Inc.AVITA Medical® is a
commercial-stage regenerative medicine company transforming the
standard of care in wound care management and skin restoration with
innovative devices. At the forefront of our platform is the RECELL®
System, approved by the U.S. Food and Drug Administration for the
treatment of thermal burn wounds and full-thickness skin defects,
and for repigmentation of stable depigmented vitiligo lesions.
RECELL harnesses the regenerative properties of a patient’s own
skin to create Spray-On Skin™ Cells, delivering a transformative
solution at the point-of-care. This breakthrough technology serves
as the catalyst for a new treatment paradigm enabling improved
clinical outcomes. In the United States, AVITA Medical also holds
the exclusive rights to market, sell, and distribute PermeaDerm®, a
biosynthetic wound matrix, and Cohealyx™, an AVITA Medical-branded
collagen-based dermal matrix.
In international markets, the RECELL System is approved to
promote skin healing in a wide range of applications including
burns, full-thickness skin defects, and vitiligo. The RECELL System
is TGA-registered in Australia, has received CE mark approval in
Europe, and has PMDA approval in Japan.
To learn more, visit www.avitamedical.com.
Authorized for release by the Chief Financial Officer of AVITA
Medical, Inc.
Investor & Media Contact:
Jessica Ekeberg
Phone +1-661-904-9269
investor@avitamedical.com
media@avitamedical.com
Avita Medical (NASDAQ:RCEL)
Historical Stock Chart
From Oct 2024 to Nov 2024
Avita Medical (NASDAQ:RCEL)
Historical Stock Chart
From Nov 2023 to Nov 2024